1. A brief synopsis of monoclonal antibody for the treatment of various groups of diseases;Puthenpurail;World J Pharm Pharm Sci,2021
2. Cetuximab;Chidharla,2023
3. Prospective practice survey of management of cetuximab-related skin reactions;Lugtenberg;Support Care Cancer,2021
4. Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents;Borovicka;Arch Dermatol,2011
5. Adverse reaction to cetuximab, an epidermal growth factor receptor inhibitor;Štulhofer Buzina;Acta Dermatovenerol Croat,2016